92 related articles for article (PubMed ID: 12958187)
1. A critical role for C/EBPbeta binding to the AABS promoter response element in the human iNOS gene.
Guo Z; Shao L; Feng X; Reid K; Marderstein E; Nakao A; Geller DA
FASEB J; 2003 Sep; 17(12):1718-20. PubMed ID: 12958187
[TBL] [Abstract][Full Text] [Related]
2. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene.
Feng X; Guo Z; Nourbakhsh M; Hauser H; Ganster R; Shao L; Geller DA
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14212-7. PubMed ID: 12381793
[TBL] [Abstract][Full Text] [Related]
3. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.
Ganster RW; Taylor BS; Shao L; Geller DA
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8638-43. PubMed ID: 11438703
[TBL] [Abstract][Full Text] [Related]
4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters.
Chu SC; Marks-Konczalik J; Wu HP; Banks TC; Moss J
Biochem Biophys Res Commun; 1998 Jul; 248(3):871-8. PubMed ID: 9704020
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of Human Inducible Nitric Oxide Synthase by p300 Transcriptional Complex.
Guo Z; Zheng L; Liao X; Geller D
PLoS One; 2016; 11(1):e0146640. PubMed ID: 26751080
[TBL] [Abstract][Full Text] [Related]
9. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes.
Sakitani K; Nishizawa M; Inoue K; Masu Y; Okumura T; Ito S
Genes Cells; 1998 May; 3(5):321-30. PubMed ID: 9685183
[TBL] [Abstract][Full Text] [Related]
10. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
11. Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter.
Guo Z; Shao L; Du Q; Park KS; Geller DA
FASEB J; 2007 Feb; 21(2):535-42. PubMed ID: 17158780
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
15. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription.
Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C
J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
17. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
Kolyada AY; Madias NE
Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
[TBL] [Abstract][Full Text] [Related]
19. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
20. c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter.
Calonge E; Alonso-Lobo JM; Escandón C; González N; Bermejo M; Santiago B; Mestre L; Pablos JL; Caruz A; Alcamí J
J Mol Biol; 2010 Feb; 396(3):463-72. PubMed ID: 19962993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
